• About
    • About Sutro
    • Patient Resources
    • Collaborations
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Functional Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • iADCs & Antibody- Drug Conjugates
    • XpressCF+®
    • cGMP Facility
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • DEIB
      • DEIB Newsletter
    • Internships
    • Sutroites
    • Volunteer
      • Current Volunteer Opportunity
  • Contact Us
Navigation
  • About
    • About Sutro
    • Patient Resources
    • Partnerships
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • Join Our Team
    • Diversity, Equity, Inclusion and Belonging
      • DEIB Newsletter
    • Internships
    • Sutroites
  • Contact Us

Financial Results

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • News Releases
    • Events & Audio Replays
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Functional Leadership Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analysts Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Financial Info

  • Overview
  • Financial Results
  • Income Statement
  • Balance Sheet
  • Cash Flow

2022

Q3 2022

Quarter Ended Sep 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2021

Quarter Ended Sep 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2021

Quarter Ended Mar 31, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2020

FY 2020

Fiscal Year Ended Dec 31, 2020
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2020

Quarter Ended Sep 30, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2020

Quarter Ended Jun 30, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2020

Quarter Ended Mar 31, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2019

FY 2019

Fiscal Year Ended Dec 31, 2019
Earnings Release
PDF HTML
10-K Filing
PDF HTML
10-K/A Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2019

Quarter Ended Sep 30, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2019

Quarter Ended Jun 30, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2019

Quarter Ended Mar 31, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2018

FY 2018

Fiscal Year Ended Dec 31, 2018
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2018

Quarter Ended Sep 30, 2018
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Contacts
  • RSS News Feed

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-881-6500
Fax: 650-553-9659

Google Map

Tweets by SutroBio

Contact Us

General Inquires: general@sutrobio.com
Business Inquires: busdev@sutrobio.com
Investor Relations Inquires: IR@sutrobio.com
Careers: jobs@sutrobio.com

Copyright © 2023 Sutro Biopharma, Inc. South San Francisco, California, U.S.A.
Privacy Policy
  • Follow
  • Follow
  • Follow
Sign Up for Email Alerts